Algeria - Age dependency ratio (% of working-age population)

Age dependency ratio (% of working-age population) in Algeria was reported at 52.62 % in 2015, according to the World Bank collection of development indicators, compiled from officially recognized sources.



algeria age dependency ratio percent of working age population wb data
Please Paste this Code in your Website
width
height
 Preview
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Learn More Register Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Learn More Interested? Click here to contact us




Age dependency ratio is the ratio of dependents--people younger than 15 or older than 64--to the working-age population--those ages 15-64. Data are shown as the proportion of dependents per 100 working-age population.


Algeria | Health

Women who believe a husband is justified in beating his wife (any of five reasons)
59 %
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
0.6
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
32.7 %
Prevalence of anemia among children (% of children under 5)
32 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
32.7 %
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
16.1 %
Number of infant deaths
20899
Cause of death, by injury (% of total)
10.1 %
Number of under-five deaths
24269
Cause of death, by non-communicable diseases (% of total)
73.8 %
Number of neonatal deaths
14773
Adults (ages 15+) living with HIV
8600 Persons
AIDS estimated deaths (UNAIDS estimates)
200
Female adults with HIV (% of population ages 15+ with HIV)
45.73 %
Prevalence of HIV, total (% of population ages 15-49)
0.1 %
Mortality rate, under-5 (per 1,000)
25.5
Mortality rate, under-5, female (per 1,000 live births)
24
Mortality rate, under-5, male (per 1,000 live births)
26.8
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
34.9
Under-5 mortality rate (per 1,000 live births): Q2
21.4
Under-5 mortality rate (per 1,000 live births): Q3
20.7
Under-5 mortality rate (per 1,000 live births): Q4
20.8
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
20.5
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
15 %
Mortality rate; neonatal (per 1;000 live births)
15.5
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
77.2 %
Children (0-14) living with HIV
500 Persons
Prevalence of HIV, female (% ages 15-24)
0.1 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
9.4
Prevalence of HIV, male (% ages 15-24)
0.1 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
90 %
AIDS deaths in adults and children (high estimate)
1100
AIDS deaths in adults and children (low estimate)
1000
AIDS deaths in adults and children
1000
Adults (ages 15+) newly infected with HIV
500
Children (ages 0-14) newly infected with HIV
100
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
500
Incidence of HIV (% of uninfected population ages 15-49)
0.01 %
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
9 %
Children orphaned by HIV/AIDS
1000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
34 %
Adults (ages 15+) and children (0-14 years) living with HIV
8800 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
75.7 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
83.7 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
86.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
87.5 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
83.1 %
Immunization, Hib3 (% of children ages 12-23 months)
95 %
Immunization, BCG (% of one-year-old children)
99 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
97.2 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
97.9 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
99.8 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
99.6 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
97 %
Immunization, DPT (% of children ages 12-23 months)
95 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
84.8 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
91 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
93.2 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
95.3 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
91.6 %
Immunization, measles (% of children ages 12-23 months)
95 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
84.6 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
90.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
92 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
94.4 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
90.3 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
2.6 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
2 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
0.2 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
0.4 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
2.7 %
Immunization, Pol3 (% of one-year-old children)
95 %
Hospital beds
1.7
Community health workers
0.029
Nurses and midwives
1.95
Physicians
1.21
Specialist surgical workforce (per 100,000 population)
12.12
Deaths among children under five years of age due to malaria
0.5 %
Reported malaria deaths (total)
1
Incidence of malaria (per 1,000 population at risk)
0.0019
Number of maternal mortality deaths
1300
Lifetime risk of maternal death (1 in: rate varies by country)
240
Lifetime risk of maternal death
0.4193 %
Prevalence of anemia among pregnant women
31.3 %
Prevalence of syphilis (% of women attending antenatal care)
1.85 %
Smoking prevalence, females (% of adults)
0.2 %
Smoking prevalence, males (% of adults)
26 %
Risk of catastrophic expenditure for surgical care (% of people at risk)
17.2 %
Risk of impoverishing expenditure for surgical care (% of people at risk)
35.5 %
Improved sanitation facilities (% of population with access)
87.6 %
Improved sanitation facilities, urban (% of urban population with access)
89.8 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
67.3 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
87.6 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
93.3 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
92.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
95 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
96.1 %
Pregnant women receiving prenatal care
92.7 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
78.8 %
Antenatal care (doctor) (% of women with a birth): Q2
86.2 %
Antenatal care (doctor) (% of women with a birth): Q3
85 %
Antenatal care (doctor) (% of women with a birth): Q4
85.3 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
90.5 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
60.1 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
64.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
67.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
73.1 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
72.9 %
ARI treatment (% of children under 5 taken to a health provider)
66.4 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
7.4 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
6.2 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
6.6 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
5.8 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
3.5 %
Exclusive breastfeeding (% of children under 6 months)
25.7 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
94.6 %
Assistance during delivery (any skilled personnel) (% of births): Q2
96.6 %
Assistance during delivery (any skilled personnel) (% of births): Q3
96.4 %
Assistance during delivery (any skilled personnel) (% of births): Q4
97.3 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
98.7 %
Births attended by skilled health staff (% of total)
96.6 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
95.4 %
Place of delivery (births at health facility) (% of births): Q2
96.7 %
Place of delivery (births at health facility) (% of births): Q3
96.3 %
Place of delivery (births at health facility) (% of births): Q4
97.6 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
98.7 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
20.9 %
Assistance during delivery (doctor) (% of births): Q2
24.7 %
Assistance during delivery (doctor) (% of births): Q3
25.9 %
Assistance during delivery (doctor) (% of births): Q4
28 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
36.7 %
Low-birthweight babies (% of births)
6 %
Diabetes prevalence (% of population ages 20 to 79)
7.5 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
10.2 %
Prevalence of diarrhea (% of children under 5): Q2
10.5 %
Prevalence of diarrhea (% of children under 5): Q3
8.7 %
Prevalence of diarrhea (% of children under 5): Q4
9.1 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
7.9 %
Prevalence of underweight, weight for age, female (% of children under 5)
3 %
Prevalence of underweight, weight for age, male (% of children under 5)
3.1 %
Malnutrition prevalence, weight for age (% of children under 5)
3 %
Malaria cases reported
55
Maternal mortality ratio (modeled estimate, per 100,000 live births)
140
Maternal mortality ratio (national estimate; per 100;000 live births)
117
People practicing open defecation, rural (% of rural population)
2.3 %
People practicing open defecation, urban (% of urban population)
0.2 %
People practicing open defecation (% of population)
0.8 %
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
41.7 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q1 (lowest)
54.3 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q2
50.8 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q3
52.7 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q4
52.6 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q5 (highest)
61.4 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q1 (lowest)
29.2 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q2
32.5 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q3
34.8 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q4
37.1 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q5 (highest)
38.8 %
Diarrhea treatment (% of children under 5 who received ORS packet)
25.3 %
Prevalence of overweight, female (% of female adults)
61.3 %
Prevalence of overweight, male (% of male adults)
51.5 %
Prevalence of overweight, weight for height, female (% of children under 5)
11.9 %
Prevalence of overweight, weight for height, male (% of children under 5)
12.8 %
Prevalence of overweight (% of children under 5)
12.4 %
Prevalence of stunting, height for age, female (% of children under 5)
10.7 %
Prevalence of stunting, height for age, male (% of children under 5)
12.6 %
Malnutrition prevalence, height for age (% of children under 5)
11.7 %
Suicide mortality rate (per 100,000 population)
3.1
Mortality caused by road traffic injury (per 100,000 people)
23.7
Prevalence of wasting, weight for height, female (% of children under 5)
3.8 %
Prevalence of wasting, weight for height, male (% of children under 5)
4.4 %
Prevalence of wasting (% of children under 5)
4.1 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
1.1 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
1.7 %
Prevalence of severe wasting, weight for height (% of children under 5)
1.4 %
Tuberculosis treatment success rate (% of registered cases)
88 %
Tuberculosis case detection rate (all forms)
80
Incidence of tuberculosis (per 100,000 people)
75
Tuberculosis death rate (per 100,000 people)
8.2
Deaths due to tuberculosis among HIV-negative people, high uncertainty bound (per 100,000 population)
26
Deaths due to tuberculosis among HIV-negative people, low uncertainty bound (per 100,000 population)
4.9
Tetanus toxoid vaccination (% of live births): Q1 (lowest)
25.9 %
Tetanus toxoid vaccination (% of live births): Q2
34.7 %
Tetanus toxoid vaccination (% of live births): Q3
33.1 %
Tetanus toxoid vaccination (% of live births): Q4
33.9 %
Tetanus toxoid vaccination (% of live births): Q5 (highest)
37 %
Newborns protected against tetanus
92 %
External resources for health (% of total expenditure on health)
0.0316 %
Out-of-pocket health expenditure (% of total expenditure on health)
26.5 %
Out-of-pocket health expenditure (% of private expenditure on health)
97.28 %
Health expenditure per capita
362 USD
Health expenditure per capita, PPP (constant 2005 international $)
932
Health expenditure, private (% of GDP)
1.96 %
Health expenditure, public (% of total health expenditure)
72.76 %
Health expenditure, public (% of government expenditure)
9.9 %
Health expenditure, public (% of GDP)
5.24 %
Health expenditure, total (% of GDP)
7.21 %
Refugee population by country or territory of asylum
94182
Refugee population by country or territory of origin
3490
Number of people who are undernourished
1900000
Prevalence of undernourishment (% of population)
5 %
Depth of the food deficit (kilocalories per person per day)
20
Depth of hunger (kilocalories per person per day)
180
Consumption of iodized salt (% of households)
60.71 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
10.47
Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)
79.84 %
Completeness of total death reporting (% of reported total deaths to estimated total deaths)
91.09 %
Mortality rate, adult, female (per 1,000 female adults)
82.94
Mortality rate, adult, male (per 1,000 male adults)
133
Birth rate, crude
23.69
Death rate, crude
5.11
Current use of contraception (modern method) (% of married women): Q1 (lowest)
48.9 %
Current use of contraception (modern method) (% of married women): Q2
46.3 %
Current use of contraception (modern method) (% of married women): Q3
45.9 %
Current use of contraception (modern method) (% of married women): Q4
48.7 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
49.8 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
49.5 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
56.9 %
Current use of contraception (any method) (% of married women): Q2
55.9 %
Current use of contraception (any method) (% of married women): Q3
56.2 %
Current use of contraception (any method) (% of married women): Q4
57.2 %
Current use of contraception (any method) (% of married women): Q5 (highest)
59.6 %
Contraceptive prevalence (% of women ages 15-49)
57.1 %
Mortality rate, infant, female (per 1,000 live births)
20.5
Mortality rate, infant (per 1,000 live births)
21.9
Mortality rate, infant, male (per 1,000 live births)
23.2
Infant mortality rate (per 1,000 live births): Q1 (lowest)
31.3
Infant mortality rate (per 1,000 live births): Q2
17.7
Infant mortality rate (per 1,000 live births): Q3
18.2
Infant mortality rate (per 1,000 live births): Q4
20.3
Infant mortality rate (per 1,000 live births): Q5 (highest)
17.5
Life expectancy at birth, female (years)
77.46 years
Life expectancy at birth, total (years)
75.04 years
Life expectancy at birth, male (years)
72.74 years
Fertility rate, total (births per woman)
2.8
Total fertility rate (TFR) (births per woman): Q1 (lowest)
3.1
Total fertility rate (TFR) (births per woman): Q2
3
Total fertility rate (TFR) (births per woman): Q3
2.5
Total fertility rate (TFR) (births per woman): Q4
2.6
Total fertility rate (TFR) (births per woman): Q5 (highest)
2.3
Survival to age 65, female (% of cohort)
85.56 %
Survival to age 65, male (% of cohort)
77.48 %
Women who were first married by age 18 (% of women ages 20-24)
2.5 %
Female population 00-04
2267000 Persons
Population ages 0-4, female (% of female population)
11.45 %
Male population 00-04
2346000 Persons
Population ages 0-4, male (% of male population)
11.69 %
Female population 05-09
1977000 Persons
Population ages 5-9, female (% of female population)
9.54 %
Male population 05-09
2038000 Persons
Population ages 5-9, male (% of male population)
9.71 %
Female population 10-14
1491000 Persons
Population ages 10-14, female (% of female population)
7.27 %
Male population 10-14
1536000 Persons
Population ages 10-14, male (% of male population)
7.41 %
Female population 15-19
1435000 Persons
Population ages 15-19, female (% of female population)
7.49 %
Male population 15-19
1490000 Persons
Population ages 15-19, male (% of male population)
7.69 %
Female population 20-24
1715000 Persons
Population ages 20-24, female (% of female population)
8.97 %
Male population 20-24
1765000 Persons
Population ages 20-24, male (% of male population)
9.1 %
Female population 25-29
1861000 Persons
Population ages 25-29, female (% of female population)
9.47 %
Male population 25-29
1887000 Persons
Population ages 25-29, male (% of male population)
9.48 %
Female population 30-34
1816000 Persons
Population ages 30-34, female (% of female population)
9.06 %
Male population 30-34
1828000 Persons
Population ages 30-34, male (% of male population)
9.01 %
Female population 35-39
1579000 Persons
Population ages 35-39, female (% of female population)
7.72 %
Male population 35-39
1582000 Persons
Population ages 35-39, male (% of male population)
7.64 %
Female population 40-44
1285000 Persons
Population ages 40-44, female (% of female population)
6.28 %
Male population 40-44
1275000 Persons
Population ages 40-44, male (% of male population)
6.15 %
Female population 45-49
1083000 Persons
Population ages 45-49, female (% of female population)
5.35 %
Male population 45-49
1070000 Persons
Population ages 45-49, male (% of male population)
5.23 %
Female population 50-54
924000 Persons
Population ages 50-54, female (% of female population)
4.53 %
Male population 50-54
915000 Persons
Population ages 50-54, male (% of male population)
4.46 %
Female population 55-59
739000 Persons
Population ages 55-59, female (% of female population)
3.62 %
Male population 55-59
753000 Persons
Population ages 55-59, male (% of male population)
3.67 %
Female population 60-64
618000 Persons
Population ages 50-64, female (% of female population)
3.02 %
Male population 60-64
644000 Persons
Population ages 50-64, male (% of male population)
3.12 %
Female population 65-69
426000 Persons
Population ages 65-69, female (% of female population)
2.03 %
Male population 65-69
430000 Persons
Population ages 65-69, male (% of male population)
2 %
Population ages 65 and above (% of total)
5.94 %
Female population 70-74
324000 Persons
Population ages 70-74, female (% of female population)
1.62 %
Male population 70-74
296000 Persons
Population ages 70-74, male (% of male population)
1.45 %
Female population 75-79
257000 Persons
Population ages 75-79, female (% of female population)
1.29 %
Male population 75-79
219000 Persons
Population ages 75-79, male (% of male population)
1.08 %
Population ages 80 and above, female
270000 Persons
Population ages 80 and above, female (% of female population)
1.29 %
Male population 80+
237000 Persons
Age population, age 06, female, interpolated
397063 Persons
Age population, age 06, male, interpolated
409447 Persons
Age population, age 07, female, interpolated
376432 Persons
Age population, age 07, male, interpolated
388026 Persons
Age population, age 08, female, interpolated
355250 Persons
Age population, age 08, male, interpolated
366107 Persons
Age population, age 09, female, interpolated
334407 Persons
Age population, age 09, male, interpolated
344613 Persons
Age population, age 10, female, interpolated
313523 Persons
Age population, age 10, male
323087 Persons
Age population, age 11, female, interpolated
292218 Persons
Age population, age 11, male
301073 Persons
Age population, age 12, female, interpolated
277741 Persons
Age population, age 12, male
286363 Persons
Age population, age 13, female, interpolated
273526 Persons
Age population, age 13, male
282621 Persons
Age population, age 14, female, interpolated
276650 Persons
Age population, age 14, male
286645 Persons
Age population, age 15, female, interpolated
280044 Persons
Age population, age 15, male, interpolated
290869 Persons
Age population, age 16, female, interpolated
284267 Persons
Age population, age 16, male, interpolated
295969 Persons
Age population, age 17, female, interpolated
291867 Persons
Age population, age 17, male, interpolated
304067 Persons
Age population, age 18, female, interpolated
303124 Persons
Age population, age 18, male, interpolated
315183 Persons
Age population, age 19, female, interpolated
316664 Persons
Age population, age 19, male, interpolated
328144 Persons
Age population, age 20, female, interpolated
330856 Persons
Age population, age 20, male, interpolated
341813 Persons
Age population, age 21, female, interpolated
346053 Persons
Age population, age 21, male, interpolated
356487 Persons
Age population, age 22, female, interpolated
358211 Persons
Age population, age 22, male, interpolated
367934 Persons
Age population, age 23, female, interpolated
365154 Persons
Age population, age 23, male, interpolated
373944 Persons
Age population, age 24, female, interpolated
368371 Persons
Age population, age 24, male, interpolated
376091 Persons
Age population, age 25, female, interpolated
371519 Persons
Age population, age 25, male, interpolated
378140 Persons
Age dependency ratio (% of working-age population)
52.62 %
Age dependency ratio, old (% of working-age population)
9.06 %
Age dependency ratio, young (% of working-age population)
43.56 %
Population, female (% of total)
49.69 %
Completeness of birth registration, rural
99.5 %
Completeness of birth registration, urban
99.7 %
Completeness of birth registration
99.6 %
Unmet need for family planning (for limiting) (% of married women): Q1 (lowest)
2.5 %
Unmet need for family planning (for limiting) (% of married women): Q2
2.2 %
Unmet need for family planning (for limiting) (% of married women): Q3
2.5 %
Unmet need for family planning (for limiting) (% of married women): Q4
1.7 %
Unmet need for family planning (for limiting) (% of married women): Q5 (highest)
2 %
Unmet need for family planning (for spacing) (% of married women): Q1 (lowest)
5.5 %
Unmet need for family planning (for spacing) (% of married women): Q2
5.4 %
Unmet need for family planning (for spacing) (% of married women): Q3
4.2 %
Unmet need for family planning (for spacing) (% of married women): Q4
4.9 %
Unmet need for family planning (for spacing) (% of married women): Q5 (highest)
4 %
Unmet need for contraception (% of married women ages 15-49)
7 %
Unmet need for family planning (total) (% of married women): Q1 (lowest)
8 %
Unmet need for family planning (total) (% of married women): Q2
7.6 %
Unmet need for family planning (total) (% of married women): Q3
6.6 %
Unmet need for family planning (total) (% of married women): Q4
6.6 %
Unmet need for family planning (total) (% of married women): Q5 (highest)
6 %